Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices 84149 

increase in synthetic opioids, including 

illicitly manufactured fentanyl (IMF), 

and a resurgence of stimulants, 

particularly methamphetamine, into the 

illegal drug supply. 

Multisector collaboration is critical to 

preventing overdoses and saving lives. 

Two key sectors in this response are 

public health and public safety, as they 

are both on the front lines and both 

tasked with improving community 

safety and well-being. CDC 

demonstrates strong commitment to 

public health/public safety partnerships 

through implementation of several 

national programs, including the 

Overdose Response Strategy (ORS). 

ORS teams support public health and 

public safety entities in their 

jurisdictions by: 

• Sharing data systems to inform 

rapid and effective community overdose 

prevention efforts. 

• Supporting immediate, evidencebased response efforts that can directly 

reduce overdose deaths. 

• Designing and using promising 

strategies at the intersection of public 

health and public safety. 

• Disseminating information to 

support the implementation of 

evidence-informed overdose prevention 

strategies. 

As the ORS is one of CDC’s flagship 

overdose prevention programs, and 

partnering with public safety is one of 

CDC’s key overdose prevention 

strategies, a greater understanding of the 

impact and effectiveness of the ORS is 

needed to inform program 

enhancements and improvements. This 

ICR focuses on a survey and a reporting 

tool that ORS teams and their partners 

will complete to provide critical data to 

CDC for program monitoring, to inform 

technical assistance and guidance 

documents produced by CDC or other 

partners, and to assess the extent to 

which the ORS program is achieving the 

goal of supporting public health and 

public safety partnerships to reduce 

drug overdose. It will also provide CDC 

with the capacity to respond in a timely 

manner to requests for information 

about the program from the Department 

of Health and Human Services (HHS), 

the White House, Congress, and other 

sources. Information collected will be 

disseminated to ORS teams and to the 

public via an annual Program 

Evaluation Report and an ORS Annual 

Report. Data from both reports will 

largely be used to develop programmatic 

reports, tools, and implementation 

guides for the purposes of program 

improvement. 

CDC requests OMB approval for an 

estimated 633 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

ORS Public Health Analysts ................. ORS Annual Evaluation Survey-PHA .. 61 1 30/60 31 

ORS Quarterly Reporting Template ..... 61 4 1 244 

ORS Drug Intelligence Officers ............ ORS Annual Evaluation Survey-DIO ... 61 1 30/60 31 

ORS Quarterly Reporting Template ..... 61 4 1 244 

State, territory, county and city health 

department staff.

ORS Annual Evaluation Survey-Public 

Health Partner.

70 1 30/60 35 

HIDTA staff ........................................... ORS Annual Evaluation Survey-Public 

Safety Partner.

70 1 30/60 35 

CDCF ORS National Team Staff .......... ORS Annual Evaluation Survey-ORS 

Management/Coordination Team.

25 1 30/60 13 

Total ............................................... ............................................................... ...................... .......................... .................... 633 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–24303 Filed 10–18–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–1274; Docket No. CDC–2024– 

0080] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on the Million Hearts®

Hospital & Health System Recognition 

Program. This program recognizes 

institutions working systematically to 

improve the cardiovascular health of the 

population and communities they serve. 

DATES: CDC must receive written 

comments on or before December 20, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0080 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 


lotter on DSK11XQN23PROD with NOTICES1
84150 Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Million Hearts® Hospitals & Health 

Systems Recognition Program (OMB 

Control No. 0920–1274, Exp. 10/31/ 

2025)—Extension—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention CDC). 

Background and Brief Description 

Heart disease, stroke and other 

cardiovascular diseases (CVDs) kill over 

800,000 Americans each year, 

accounting for one in every three 

deaths. CVD is the nation’s number one 

killer among both men and women and 

the leading cause of health disparities. 

Million Hearts®, a national, publicprivate initiative co-led by the Centers 

for Disease Control and Prevention 

(CDC) and the Centers for Medicare & 

Medicaid Services (CMS), was 

established to address this issue. 

Whether migrating towards value-based 

reimbursement or simply striving for a 

significant impact in reducing the 

devastation of heart attacks and strokes, 

clinical organizations are positioned to 

improve the health of the population 

they serve by implementing highimpact, evidence-based strategies. 

Achieving a Million Hearts® Hospitals & 

Health Systems designation signals a 

commitment to not only clinical quality, 

but population health overall. 

Initially launched in 2020, the 

Program will continue to recognize 

institutions that are working to 

systematically improve the 

cardiovascular health of the population 

and communities that they serve by 

implementing strategies under the 

Million Hearts® priority areas of: 

Keeping People Healthy; Optimizing 

Care; Improving Outcomes for Priority 

Populations; and Innovating for Health. 

CDC anticipates that new applicants 

will range from health systems with 

multiple hospitals, hospitals with and 

without ambulatory medical practices, 

and medical practices not affiliated with 

hospitals. 

Any clinical entity whose leaders 

consider it eligible may apply. 

Recognition can be achieved by a robust 

commitment to implement specific 

strategies, by implementing specific 

strategies, and most importantly, by 

achieving specific outcomes. Applicants 

will complete the Million Hearts®

Hospitals & Health Systems Recognition 

Program application, indicating the 

areas in which they are committing to 

implement Million Hearts® strategies; 

areas in which they have implemented 

key strategies; and those strategies for 

which they have achieved outcomes/ 

results. Applicants must address a 

minimum of one strategy in at least 

three of the four priority areas (Keeping 

People Healthy, Optimizing Care, 

Improving Outcomes for Priority 

Populations, and Innovating for Health) 

that are outlined in the application. 

However, they are encouraged to target 

as many strategies as is appropriate for 

their institution. Applicants will be 

subject to a background check. 

The Million Hearts® Hospitals and 

Health Systems designation conveys 

that the institution is committed to 

preventing heart attacks and strokes by 

a combination of efforts that are about 

Keeping People Healthy, Optimizing 

Care, Improving Outcomes for Priority 

Populations and Innovating for Health. 

All applicants with reported outcomes 

and a select number of those who are 

committing to implement or are 

implementing Million Hearts®

strategies, will be asked to participate in 

a semi-structured, qualitative interview. 

The purpose of the interview is to 

obtain in-depth contextual information 

about the Million Hearts® strategies and 

facilitators used to achieve improved 

cardiovascular outcomes among the 

applicant’s patient population. 

Applicants with reported outcomes will 

receive increased recognition from 

Million Hearts® by having their success 

stories highlighted by Million Hearts®

by placement on the Million Hearts®

website, e-newsletter. The program’s 

web-based application will stay open 

throughout the year and applications 

will be reviewed on a quarterly basis 

and recognized within six months of 

acceptable review. CDC estimates that 

information will be collected from up to 

50 applicants per year. 

The overall goal of the Million 

Hearts® initiative is to prevent one 

million heart attacks and strokes. 

Promoting evidence-based strategies 

that prevent CVD is one focus of the 

initiative. CDC will use the information 

collected through the Million Hearts®

Hospitals & Health Systems Recognition 

Program to increase widespread 

attention on successful and sustainable 

implementation strategies, improve 

understanding of these strategies at the 

practice level, bring visibility to 

organizations that commit, implement, 

or have implemented Million Hearts®

strategies and motivate other hospitals 

and health systems to strengthen their 

efforts to address CVD. 

OMB approval is requested for three 

years. CDC requests OMB approval for 

an estimated 149 annual burden hours. 

Participation is voluntarily and there are 

no costs to respondents other than their 

time. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices 84151 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. 

burden per 

response 

(in hrs.) 

Total 

burden 

(in hrs.) 

Medical & Health Service Manager ...... Recognition Program Application ......... 50 1 160/60 134 

Medical & Health Service Manager ...... Interview Guide .................................... 30 1 30/60 15 

Total ............................................... ............................................................... ...................... .......................... .................... 149 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–24307 Filed 10–18–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–1355] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Evaluation of 

the Overdose Data to Action Technical 

Assistance Hub’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on May 7, 

2024, to obtain comments from the 

public and affected agencies. CDC 

received one non-substantive public 

comment related to the previous notice. 

This notice serves to allow an additional 

30 days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Evaluation of the Overdose Data to 

Action Technical Assistance Hub (OMB 

Control No. 0920–1355, Exp. 11/30/ 

2024)—Revision—National Center for 

Injury Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) requests approval of 

this Revision to support the evaluation 

of technical assistance (TA) provided for 

the Overdose Data to Action (OD2A) in 

States (OD2A–S) and OD2A: Limiting 

Overdose through Collaborative Actions 

in Localities (LOCAL) (OD2A: LOCAL) 

programs. OD2A–S and OD2A: LOCAL 

are cooperative agreements funded in 

2023 to focus on comprehensive and 

interdisciplinary opioid overdose 

prevention efforts in 49 state health 

departments, 39 localities, Puerto Rico, 

and Washington, DC. Each program 

consists of two required components— 

a surveillance component and a 

prevention component. OD2A recipients 

implement a combination of activities 

across nine State strategies and eight 

local strategies within these components 

to gain access to high quality and 

complete data on opioid prescribing and 

overdoses. The data is used to inform 

prevention and response efforts in their 

jurisdictions. 

CDC developed and deployed a 

technical assistance (TA) hub (hereafter 

referred to as the OD2A TA Center) to 

deliver comprehensive technical 

assistance and training to support the 

successful implementation and 

evaluation of surveillance and 

prevention activities. The OD2A TA 

Center is designed to enhance the 

efficiency, coordination, and 

effectiveness of TA efforts by 

streamlining and centralizing the 

provision of overdose surveillance and 

prevention TA. TA to OD2A recipients 

is divided into four different levels with 

multiple modes of TA delivery and 

involves a wide range of TA providers 

including CDC staff, internal and 

external subject matter experts (SMEs) 

and program partners. 

The evaluation consists of web-based 

surveys designed to collect process and 

outcome measures about TA access, 

utilization, and outcomes across all 

OD2A recipient programs. The 

Technical Assistance Feedback Form 

will be administered to collect 

immediate feedback following 

individual TA encounters and group 

events such as webinars and in-person 

trainings. The Annual OD2A TA Survey 

will be distributed twice (mid-point and 

final) to assess satisfaction with overall 

TA provided and the extent to which 

TA supports informed implementation 

of OD2A strategies. The information 

obtained through this evaluation will 

allow TA providers to assess OD2A 

recipients’ experience and utility of 

knowledge and resources gained 

through individual TA support, peer-topeer sessions, and other group trainings. 

To capture participants’ experiences 

attending various Communities of 


lotter on DSK11XQN23PROD with NOTICES1